Plain-English translation of NCT06126692 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large European study following 600 people with severe asthma who are starting biologic medications — highly targeted treatments designed to calm specific parts of the immune system. Researchers want to understand why some people respond very well to these medications while others see little benefit, and whether severe asthma can actually go into remission with the right treatment.
Even with today's advanced biologic medications, not everyone with severe asthma improves the same way. Doctors need better tools to predict who will benefit from which treatment, and to know whether it's possible to achieve long-term remission or control of severe asthma.
You likely qualify if…
You likely don't qualify if…
You would start taking a biologic medication as prescribed by your doctor, and the study team would follow you closely for three years. You'll have regular clinic visits (the exact schedule depends on which biologic you're taking) where researchers will collect blood samples, ask about your asthma symptoms and how often you've had attacks, and monitor how well the medication is working for you. The goal is to gather detailed information about your response to treatment so researchers can better understand these medications and help future patients.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Denmark
Netherlands